Nevro (NYSE:NVRO): Q3 GAAP EPS of -$0.58 beats by $0.26.
Revenue of $100.16M (+4.7% Y/Y) beats by $7.89M.
Shares +0.38%.
Wednesday, November 6, 2019
Livongo Health EPS beats by $0.08, beats on revenue
Livongo Health (NASDAQ:LVGO): Q3 Non-GAAP EPS of -$0.05 beats by $0.08; GAAP EPS of -$0.27 beats by $0.03.
Revenue of $46.66M (+148.5% Y/Y) beats by $3.96M.
Shares +14.62%.
Hologic FQ4 top line up 6%; earnings down 21%
Hologic (NASDAQ:HOLX) fiscal Q4 results:
Revenue: $865.8M (+6.4%); Breast Health: $342.6M (+6.3%).
Net income: $39.9M (-21.0%); non-GAAP net income: $175.0M (+10.3%); EPS: $0.15 (-16.7%); non-GAAP EPS: $0.65 (+12.1%).
Cash flow ops (FY): $649.5M (-11.4%).
Fiscal Q1 guidance: Revenue: $835M – 850M; EPS: $0.33 – 0.35; non-GAAP EPS: $0.59 – 0.61.
Fiscal 2020 guidance: Revenue: $3,450M – 3,500M; EPS: $1.59 – 1.64; non-GAAP EPS: $2.60 – 2.65.
Shares up 2% after hours.
Previously: Hologic EPS in-line, beats on revenue (Nov. 6)
Orchard Therapeutics EPS beats by $0.05, beats on revenue
Orchard Therapeutics (NASDAQ:ORTX): Q3 GAAP EPS of -$0.38 beats by $0.05.
Revenue of $1.92M (+38.1% Y/Y) beats by $1.51M.
Natera EPS beats by $0.22, beats on revenue
Natera (NASDAQ:NTRA): Q3 GAAP EPS of -$0.33 beats by $0.22.
Revenue of $77.9M (+19.3% Y/Y) beats by $3.93M.
Subscribe to:
Comments (Atom)